Journals in Pharmacology
Journals in Pharmacology
Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.
- ISSN: 0955-2863
The Journal of Nutritional Biochemistry
Devoted to advancements in nutritional sciences, The Journal of Nutritional Biochemistry presents experimental nutrition and clinical nutrition research as it interfaces with biochemistry, molecular biology, physiology, and toxicology. The scope of the journal includes the broad area of in vivo and in vitro studies of mechanistic aspects of nutritional sciences. Preferred manuscripts include studies, which focus on nutrients and/or bioactive compounds with nutritional value derived from diets/whole foods as it relates to: biochemistry, molecular biology, toxicology, immunology or physiology and human health and diseases.Rigorous reviews by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research articles, The Journal of Nutritional Biochemistry also periodically publishes emerging issues, experimental methods, and other types of articles such as but not limited to policy statements.Contact InformationReto Asmis, Ph.D, Editor-in-Chief The Journal of Nutritional Biochemistry Professor, Internal Medicine, Section on Molecular Medicine Wake Forest School of Medicine Medical Center Boulevard, Winston-Salem, NC 27157 E-mail address: [email protected]...- ISSN: 0899-9007
Nutrition
The International Journal of Applied and Basic Nutritional SciencesFounded by Michael M. Meguid in the early 1980's, Nutrition presents advances in nutrition research and science, informs its readers on new and advancing technologies and data in clinical nutrition practice, encourages the application of outcomes research and meta-analyses to problems in patient-related nutrition; and seeks to help clarify and set the research, policy and practice agenda for nutrition science to enhance human well-being in the years ahead. Papers on nutrition-related plant or animal sciences are unlikely to be considered as they are outside the main focus of the Journal.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center- ISSN: 1877-1297
Currents in Pharmacy Teaching and Learning
Currents in Pharmacy Teaching and Learning is devoted to dissemination of high quality, peer-reviewed scholarship relevant to all areas of pharmacy education—promoting educational research excellence. The Journal maintains a particular focus in two major areas: pharmacy faculty development in the scholarship of teaching and learning and the scholarship of interprofessional pharmacy education. With diverse editorial board members, authors, and peer reviewers, the Journal engages a variety of stakeholders in pharmacy education: educators, researchers, faculty practitioners, as well as interprofessional colleagues. Diverse author contributions are within original research, review articles, commentaries, and letters categories.Original research topics include, but are not limited to:Scholarship of Teaching and Learning: teaching/learning strategies; interprofessional educationQuality Improvement - assessment of programmatic/curricu... outcomesCurricular Revision – design, implementation, evaluationNew school/program strategiesAttitudes/... within pharmacy education- ISSN: 0149-2918
Clinical Therapeutics
The International Peer-Reviewed Journal of Drug TherapyClinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolera-bility in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability, and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.In addition to feature articles published monthly, each issue of Clinical Therapeutics features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. Submit your manuscript at https://www.editoria...- ISSN: 0378-5173
International Journal of Pharmaceutics
The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.- ISSN: 0891-5849
Free Radical Biology & Medicine
An official JOURNAL of the Society for Redox Biology and Medicine and the Society for Free Radical Research-Europe; affiliate journal of the International Society for Free Radical Research (SFRRI)Free Radical Biology and Medicine is the premier forum for publishing ground-breaking research in the redox biology of both health and disease. We focus on signal transduction and redox signaling; oxidative stress; reductive stress; redox stress; nitrosative stress; aging and age-related diseases; redox biology in skeletal and cardiac muscle, exercise science, and sports medicine; metabolic regulation and metabolic diseases; mitochondrial function and signaling; homeostatic mechanisms and adaptive responses; redox chemistry and mechanisms; materials and nanomaterials; non-thermal plasmas; microorganisms, fungi, plants, insects, animals, and humans; and antioxidant enzymes, pathways, and networks. We welcome both full-length and short Research Communications, Hypothesis Papers, Reviews, Mini Reviews, Graphical Reviews, and Critical Methods Papers. Free Radical Biology and Medicine also commissions themed Special Issues aimed at highlighting recent advances in both basic and clinical fields, with a particular focus on mechanisms underlying altered metabolism and redox signalling.- ISSN: 0091-3057
Pharmacology Biochemistry and Behavior
Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published.Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet.Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system.Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.Benefits to authors We provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.- ISSN: 0163-7258
Pharmacology & Therapeutics
Pharmacology & Therapeutics presents lucid, critical and authoritative reviews of currently important topics in pharmacology, including the actions of drugs, and/or the exploitation of drug targets.Disease pathophysiology is relevant provided it is part of a narrative around drug actions or new drug targets.Pharmacology & Therapeutics only publishes invited review articles. Proposals for review articles are not accepted.Founded in 1976, Pharmacology & Therapeutics continues to be among the top 10 most cited journals in pharmacology.- ISSN: 0378-4274
Toxicology Letters
Official Journal of EUROTOXAffiliated with Austrian Society of ToxicologyAn international journal for the rapid publication of novel reports on a range of aspects of toxicology, especially mechanisms of toxicity.Toxicology Letters serves as a multidisciplinary forum for research in toxicology. The prime aim is the rapid publication of research studies that are both novel and advance our understanding of a particular area. In addition to hypothesis-driven studies on mechanisms of mammalian toxicity, Toxicology Letters welcomes seminal work in the following areas:In silico toxicologyToxicokine... pharmacokinetic (PBPK) modelingSystems toxicologyPredictive toxicology3R research in toxicologyNew approach methodology (NAMs)Adverse outcome pathways (AOPs)Integrated testing strategiesSystematic and narrative reviews and mini-reviews in various areas of toxicology will be published. Clinical, occupational and safety evaluation, hazard and risk assessment, regulatory toxicology, impact on man, animal and environment studies of sufficient novelty to warrant rapid publication will be considered. Toxicology Letters also publishes editorials, commentaries and contemporary issues in toxicology.The following types of work are not within the scopes of Toxicology Letters:Ecotoxicolog... studiesCase studiesChemopreventi... studiesPharmacologic... investigationsAuthor... are advised to follow the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments; https://arriveguidel... and the OECD guidance document on Good In Vitro Method Practices (GIVIMP; https://www.oecd.org... In vitro or in vivo investigations conducted at concentrations or doses of no relevance to human or animal exposure will not be considered. Routes of exposure other than those relevant to human or animal exposure need to be justified. Assessment of dose-response should be an integral component of any toxicological research report. Unless adequately justified, studies conducted at a single dose level may not be considered. Test materials must be chemically defined and characterized. Investigations of chemically undefined plant extracts or uncharacterized nanoparticles will not be considered.- ISSN: 0367-326X
Fitoterapia
The Journal for the Study of Medicinal PlantsA Q1-ranked journal in the category of 'Agricultural and Biological Sciences' (Scopus).Fitoterapia is a Journal dedicated to medicinal plants and fungi and to the bioactive natural products produced by these organisms. It publishes original contributions in seven major areas:1. Chemical characterization of active ingredients of medicinal plants and fungi, including their endophytes 2. New analytical approaches for dereplication and standardization of biologically active extracts and metabolites from plant resources 3. Identification of bioactivity in plant and fungal extracts and in their constituents 4. Identification of biological targets and mechanism of activity of plant and fungal extracts 5. Production and genomic characterization of medicinal plants biomass 6. Biosynthesis of bioactive natural products of plant, fungi and endophytic origin 7. Critical reviews of the composition, history, clinical and legal status of medicinal plants, and accounts on topical issues.Contributions reporting the following are NOT normally considered for publication: 1. Activity data on crude extracts that have not been characterized by analysis of their major constituents (HPLC fingerprint, LC/MS or NMR). Data on the extract composition simply taken from the literature are not acceptable. Characterization of only a few constituents is generally considered too partial. 2. Studies on the bioactivity of pure compounds purchased or obtained by Authors without any study or relationship with the producing organism. 3. Unexceptional and predictable bioactivity (e.g. antioxidant properties of phenolics or antibacterial activity of essential oils). 4. Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded. 5. Genomic, transcriptomic and pharmacological studies without convincing wet lab experiments, or with little correlation to bioactive natural compounds.In addition, the following immediate rejection criteria apply: RULE 1: The manuscript does not fall into any of the areas of interest of the Journal. RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control. RULE 3: The botanical source is not clearly identified, authenticated, and documented (voucher). RULE 4: Characterization of new compounds without spectral supporting material. RULE 5: Bioactivity is not relevant to in vivo situations. RULE 6: Reviews on topics already covered in the recent literature.